Regulatory
Auditor actions, SEBI matters, compliance disclosures.
US slaps 3.68% preliminary CVD on Graphite India exports
US imposes preliminary 3.68% CVD on Graphite India's large diameter electrode exports. Impact unascertainable; final decision by Nov 2026. Electrodes drive most of ₹2,852 cr revenue; exports ~44%.
Astron Paper invites resolution plans as sales collapse to ₹72.5 lakh
The resolution professional has called for expressions of interest by July 25, but with no employees and negligible production, the chances of a viable bid are slim.
Ashish Kacholia dumps 7.8% Dhabriya Polywood stake, left with 0.03%
The marquee investor sold down from 7.82% to near zero between September and July, signaling a loss of confidence in the nano-cap.
NCL Industries promoters clear all pledged shares with Tata Capital
Four promoter-group members freed 1.65 million shares (3.64% of equity) on July 23, leaving zero shares encumbered with the lender.
Orissa Minerals secures EC nod for Belkundi mine
The Expert Appraisal Committee recommended environmental clearance, the first major regulatory headway since May 2025. The mine dwarfs the company's only active operation, but conditions remain.
Nikki Global promoter sells 4.67% stake in open market
Kamal Kishore Chaurasia cut his holding from 7.35% to 2.68%, becoming the second promoter-group member to exit in recent weeks. The sale comes just after a reported operational turnaround.
Medplus sees another 4.08% of equity pledged; total with Catalyst tops 17%
Catalyst Trusteeship created a pledge over 4.9 million shares on June 24. The pledgor is unnamed while promoters already have 60.7% of their holding pledged.
Alembic gets USFDA OK for Prucalopride, but $100M market faces competition
The approval adds a chronic-constipation generic to Alembic’s US pipeline, but generic competition and the company's scale make the near-term financial impact negligible.
AstraZeneca India gets Enhertu nod for early-stage breast cancer
The drug regulator cleared neoadjuvant use in HER2-positive Stage II/III breast cancer, expanding the addressable pool for the company's top oncology product, which already drove over ₹22,756 mn in FY26 revenue.
US imposes 6.99% CVD on HEG's graphite exports
HEG's large-diameter graphite electrode exports to the US now face a preliminary 6.99% countervailing duty, stacking on an existing 18% tariff. Final resolution awaited in December 2026.
Transrail Lighting plans ₹600 cr QIP, first equity raise since IPO
Board approves QIP of ~9% of market cap, interim dividend ₹3/share, and expands into drones, solar storage, data centres.
Tatia Global's governance churn deepens ahead of July 31 meet
Two key resignations and a reappointment of a previously resigned CS signal rapid turnover in compliance roles for the ₹36-cr nano-cap with trailing revenue down 49%.
Cipla wins US FDA nod for generic Advair Diskus
The approval opens a $908M asthma/COPD market, with launch in Q2 FY27. A single Form 483 observation at the New York facility adds a small caveat.
Gallantt Ispat replaces auditor, names internal CFO
Steelmaker appoints Singhi & Co. as statutory auditor after Maroti & Associates quits citing scale and commercial factors. Amit Jalan takes over as CFO from within.
Pavna keeps ₹30 cr as promoters let warrants lapse
₹30.30 crore forfeited after promoter group fails to pay balance on 24 lakh warrants. The amount is 12.8% of Pavna's market cap and avoids dilution at ₹505/share.
Fairplan Distributors sells 2% stake after board flagged concentration
The non-promoter entity trimmed its holding in Advik Capital to 21.74% via open market sales, weeks after the board raised governance concerns.
Indus Towers CFO resigns; delayed disclosure surprises market
Vikas Poddar quit on May 21, announced only with Q1 earnings on July 10. Steady results overshadowed by management uncertainty.
Rajesh Exports: no info on reported NEFRA probe
A brief clarification that neither confirms nor denies a regulatory investigation. With SEBI already probing revenue recognition, the silence heightens uncertainty.
Amara Raja pays ₹13.30 lakh GST penalty over address mismatch
A truck was detained in Kanpur because the 'ship-to' address on the tax invoice differed from the e-waybill. The company says it's a minor procedural error and will appeal.
Raconteur plans another preferential issue; dilution risk for nano-cap
Board meets on 30 July to consider issuing equity to promoters and non-promoters. No size or price yet, but the company just posted a ₹21 cr quarterly loss on ₹4 cr sales.
Integrated Proteins loses compliance officer, adding to management flux
Company Secretary Shivangi Paliwal resigns with immediate effect, citing personal reasons. The nano-cap has seen multiple board changes in recent weeks.
Supreme Holdings gets CIDCO nod for three extra floors at Belmac Infinity
The amended commencement certificate from CIDCO NAINA lifts the project from G+10 to G+13, adding saleable area for a nano-cap developer whose revenue has been sliding.
Senores delays Atlanta plant, redirects ₹65 cr of IPO funds
The sterile injectables facility at Atlanta won't be ready until Q4 FY28; the company now plans to use freed-up cash for ANDA buys and existing site expansions.
Goodluck Defence gets DGQA nod for artillery shells, opens MoD supply door
Goodluck India's defence arm is now a qualified supplier for 155mm M107 shells after passing DGQA's quality and technical standards. The certification clears the way to bid for government procurement contracts.
Vellora Impact eyes fresh fund-raise after scrapping ₹56 cr plan
Nano-cap's board will meet July 30 to consider equity, QIP, or convertible instruments. Previous capital raise was called off.
Rhetan TMT gets BIS licence for premium TMT bars, opens PSU doors
Rhetan TMT can now supply Fe500D, Fe550 and Fe550D TMT bars to government and PSU projects, completing its high-strength portfolio. No quantified orders or revenue impact disclosed.
SMC Global board approves ₹150 cr NCD issue, Q1 profit jumps 23%
Board approves public NCD issue with base size ₹75 cr and green shoe of ₹75 cr. Q1 consolidated net profit rises to ₹36.74 cr from ₹29.95 cr YoY.
Vedanta Oil & Gas gets govt nod for demerger assets; Cambay excluded
Ministry of Petroleum approves asset transfer, subject to prior liabilities. Cambay block remains contested after court dismissal.
Epuja Spiritech plans rights issue, but details still blank
A nano-cap with severely strained operations and 77% revenue drop eyes a rights issue. But the board meeting on 29 July is just an intent; key terms are unknown.
Kanel Industries board to mull rights issue on July 30
Nano-cap with losses and negative equity considers a rights issue. No terms yet; existing shareholders face dilution.
Prabhhans MD sells 15% more as promoter exodus continues
Satnam Singh's latest off-market sale reduces his stake to 25.34%, marking the third promoter exit from the ₹24-cr nano-cap in two months.
IVP gets ₹136.81 cr eviction order quashed by court
A Mumbai court has thrown out the port authority's ₹136.81 crore eviction order, removing an existential threat for IVP. The matter now goes back for fresh hearing.
Suraj Industries' subsidiary cleared to start ENA production
Rajasthan pollution board grants Consent to Operate for 125 KL/day grain-based distillery; trial runs start in 4-6 weeks.
Alok Shriram to receive 33.67% stake as gift, total promoter holding unchanged
Inter-family transfer at nil consideration exempt from open offer; scheduled for July 31, 2026. No change in business or public float.
Cropster Agro loses MD; outsider takes over amid revenue slide
Jaivikkumar Patel resigns citing personal commitments. Vijaykumar Nayak, an external hire with finance background, steps in as MD and CFO. The move comes after a 68% revenue fall in the latest quarter.
Aurobindo's biosimilars arm clears Brazil's ANVISA for Hyderabad plant
The facility already held EMA and WHO certifications. The ANVISA nod opens the door to Latin America, but for a ₹33,653 cr giant it's an incremental step, not a game-changer.
Glenmark wins U.S. pediatric approval for RYALTRIS nasal spray
FDA expands label to children 6–12, broadening the allergy brand's addressable market. For a company with over ₹16,000 cr in annual sales, the near-term revenue lift is modest but the strategic fit is clear.
PDS loses 8 months of insider-trading compliance data in server crash
A hardware failure wiped out PDS's SEBI-mandated Structured Digital Database for Nov 2025–Jun 2026. No cybersecurity breach, but the data is permanently gone.
Oswal Agro's secretarial auditor quits, flags board churn
Jay Mehta & Associates resigned effective June 20, 2026, citing frequent changes in board and key management, adding to a string of departures including CEO, CFO, and internal auditor.
Indostar Capital plans ₹6,000 cr NCD raise, more than its market cap
The board will meet on July 29 to approve the proposal, which exceeds the company's ₹4,176 cr market cap and signals an aggressive growth push.
Amraworld Agrico CFO resigns; Shivlal Bunkar steps in
Steven Hines quits both roles citing personal commitments. Bunkar, 32, takes over as whole-time director and CFO from July 2026.
Alphalogic Techsys signals possible equity-linked fundraise
The nano-cap software firm's board will meet on July 23 to consider raising funds via convertible warrants or other equity-linked securities. No size or use of proceeds disclosed yet.
Shivalik Rasayan plans equity raise; no size or price yet
Board to meet July 23 to consider a preferential, rights, or QIP issue. The nano-cap has not disclosed how much it wants or why.
Emcure's semaglutide gets CDSCO nod for fatty liver disease MASH
India's first GLP-1 receptor agonist cleared for non-cirrhotic MASH with moderate to advanced fibrosis. Poviztra adds a major new indication to its existing approvals for weight management, CVD, and adolescent obesity.
Wanbury's Tanuku API plant lands six USFDA observations
Routine cGMP inspection ends with Form 483 citing six observations at the Tanuku facility. Company says it will respond; the same site recently passed a TGA audit.
Chemplast's EDC plant shut after fire, financial hit unclear
The Inspector of Factories issued a prohibition order on July 19, halting operations at the Karaikal EDC plant. Chemplast was already nursing a ₹45 cr net loss and a ₹898 cr impairment.
Jyoti CNC promoter pledges 2.4% more shares, total encumbered at 13%
Anilkumar Virani's fresh pledge to Bajaj Finance takes promoter encumbrance to 13.07% of equity, crossing a materiality threshold and signaling increased borrowing at the promoter level.
KPI Green plugs its first Maharashtra solar plant into the grid
Charging permission for a 100 MW MAHAGENCO project turns a known order into operating capacity, but financial details remain undisclosed.
Elitecon gets first banking relief since March SEBI freeze
Kotak Mahindra Bank removed a lien after a SEBI clarification, but the relief is limited to one bank and other banks haven't acted.
CBI searches Reliance Power office; legal storm deepens
The search, linked to transactions with Reliance Commercial Finance and Reliance Home Finance, follows recent ED seizures of promoter shares worth ₹762.75 cr and an auditor's going-concern flag.
CBI raids Reliance Infra office over Reliance Finance loans
The search on July 18 comes days after the company was named an accused in a CBI chargesheet. Already under ED attachment and NCLT proceedings, the small-cap power firm now faces another regulatory escalation.
Aarti Drugs' key amines unit faces GPCB closure order
The Gujarat Pollution Control Board has ordered closure of Aarti's methylamine plant at Saykha within 15 days for water pollution violations, threatening a backward integration project.
Amara Raja's AP pollution closure orders revoked after five years
The Andhra Pradesh Pollution Control Board lifts 2021 closure orders on two manufacturing plants. The move clears a long-standing regulatory overhang for the battery maker.
Airfloa's CSR penalty doubles to ₹1.80 cr, but the sum is modest
The Regional Director dismissed Airfloa's appeals and doubled the penalty for delayed CSR transfers. At ₹1.80 cr, it is modest relative to Airfloa's ₹829 cr market cap and ₹320 cr FY26 revenue.
Alembic's partner lands tentative OK for $1.4B cancer drug
NATCO's tentative approval for generic Olaparib puts Alembic in position to distribute a blockbuster, pending patent resolution.
Natco gets tentative FDA nod for generic Lynparza; launch hinges on patent case
US FDA clears Natco's olaparib tablets as generic version of AstraZeneca's $1.4B cancer drug, but Paragraph IV litigation keeps commercial launch uncertain.
BSE freezes Frontline Corp promoters' demat accounts over compliance lapses
The freeze, effective July 16 under SEBI's penal framework, bars promoters from trading shares. For a ₹18 cr nano-cap, the governance signal is sharp.
Rane Steering gets ₹11.88 cr GST show cause notice
The notice, from July 17, cites GSTR-2A/3B mismatches for FY23. Rane plans to contest; the amount is just 0.48% of the parent's market cap.
SecUR Credentials overhauls board as losses mount
Market cap of ₹7 cr, revenue down 112%: new MD, CFO and four directors aim to fix governance amid delayed filings.
Vedanta Resources' $1B facility keeps promoter stake locked
The 56.38% promoter holding in VISL was already fully encumbered. The new Citigroup-Standard Chartered deal adds fresh covenants but no new pledge.
Vedanta Power's promoter encumbrance stays at 56.38% despite $1 bn fresh loan
A $1 billion promoter-level facility refinances group debt without adding new shares to the lock-up. The encumbered stake remains identical to the prior $1.75 bn bond – a non-event for Vedanta Power's equity.
Cipla's InvaGen unit gets single USFDA observation, no warning letter
A routine cGMP inspection at the New York facility ended with one Form 483 observation. The outcome is minor compared to more severe regulatory actions.
Toyam Sports posts ₹33.9 cr loss, auditor flags impairment and probes
Auditor ASGR & Co gave a qualified opinion on impairment provisions, NBFC registration, ongoing SEBI/ED investigations, and TDS non-compliance. The loss alone is 81% of the company's ₹42 cr market cap.
Dr. Lal PathLabs wins ₹32.66 cr ESOP tax dispute
Tax appellate order overturns a 2024 assessment disallowing the deduction, removing a contingent liability. The amount is small relative to revenue of over ₹2,700 cr.
Mizzen Ventures pulls ₹10 cr preferential issue, cites 'unavoidable circumstances'
The fundraise, approved in June 2026 and equivalent to 4.85% of market cap, is scrapped without explanation. Shareholder resolutions for the issue and authorised capital increase stand cancelled.
Filatex board loses 3 directors, appoints new company secretary
Nano-cap textiles firm appoints new company secretary and independent director to plug compliance gaps, but simultaneous director exits add to governance overhang after auditor flagged ₹242 cr in unprovided receivables.
Trio Mercantile board to formalise takeover; Joshi set for Chairman role
Kaushik Joshi, who took control via an open offer, will be appointed Chairman and MD for three years, pending shareholder nod. Three independent directors also proposed.
Olectra Greentech drawn into land PIL over EV plant site
A PIL before the Telangana High Court challenges the acquisition and allotment of 150 acres for Olectra's greenfield EV factory. The company says no immediate financial liability but the case could delay a strategically critical expansion.
Jyoti CNC promoter pledges 1% more; total encumbered hits 10.65%
Anilkumar Virani puts 23 lakh shares with JIO Credit as security for a business loan, crossing a materiality threshold.
3i Infotech drags RailTel to arbitration; RailTel counters with ₹91 cr claim
3i Infotech filed a ₹60.26 cr arbitration claim against RailTel for terminating a Wi-Fi monetisation contract. RailTel has filed a larger counterclaim of ₹91.34 cr. The amounts are small relative to RailTel's ₹10,079 cr market cap.
Paterson & Co exits India Cements Capital entirely, selling 18.42% stake
The non-promoter entity sold its remaining 40 lakh shares off-market on 17 July, completing a series of reductions from over 24% in recent weeks.
Keerthi Industries gets IBC notice over ₹4.31 cr coal bill
Coal supplier J P Associates served a demand notice under the Insolvency and Bankruptcy Code for unpaid operational debt. Keerthi, already loss-making and flagged for going-concern risk, says it will try to resolve amicably.
NCLT clears Ansal Crown revival, ending ₹58.9 cr overhang
The resolution plan for Ansal Buildwell's wholly-owned subsidiary gets NCLT approval after a 27-month CIRP. The ₹321.33 crore revival package removes a contingent liability that exceeded the parent's ₹64 crore market cap.
Kalyani Steels reopens Ginigera plant just 4 days after CPCB shutdown order
The pollution regulator conditionally revoked its closure directive on July 16, allowing Kalyani Steels to restart operations from July 17. The swift reversal removes an immediate revenue risk for the small-cap steelmaker.
Jyoti Structures loses Chairman, CEO also gone, no succession plan yet
Dr. Rajendra Prasad Singh died on July 17, 2026, leaving the power transmission firm without its top two leaders after the CEO resigned in May. No immediate succession plan was disclosed.
MT Educare loses faculty, students as insolvency bites
Mass resignations and falling enrolments hit the already distressed coaching firm; students seek transfers to rivals as the resolution professional warns of further revenue damage.
SMALLCAP World Fund cuts Ramkrishna Forgings stake below 5% threshold
The US mutual fund sold 4.56 million shares in open market, bringing its holding to 4.48% and ending mandatory disclosure obligations.
Promoter debt dwarfs Burger King India acquisition cost at ₹3,873 cr
The pledge of **16.71%** equity backs debentures worth nearly **₹3,900 cr**, far exceeding the **₹2,235 cr** deal value and approaching the company's own market cap of **₹5,650 cr**.
Belding India seeks NSE listing to expand reach post pivot
Board approved direct listing on NSE Main Board for existing shares. Currently BSE-only, micro-cap aims to boost liquidity post rebranding to EPC for data centres, defence, energy storage.
Silicon Rental's ₹9.16 cr warrant funding falls through as holders walk away
Warrant holders tied to the Motiani family let 5,50,400 warrants lapse by the July 15 deadline. The company forfeits ₹3.05 cr deposit but misses out on ₹9.16 cr, roughly 10% of its market cap.
Oswal Overseas gets NCLAT stay after settling ₹2.25 cr debt
The sugar maker reached a settlement with creditor L H Sugar Factories. NCLAT halts CIRP but orders formal withdrawal under Section 12A.
Kanungo Financiers pushes ahead with acquisition days after SEBI ban
The board meets on 22 July to finalise a share-swap deal and raise fresh funds, just 14 days after SEBI banned the company for four years.
B-Right Real Estate board to close ₹40 cr fixed deposit scheme
The July 20 meeting will shutter the retail deposit programme after a recent negative rating watch. Other agenda items, including ESOPs, are routine.
Speciality Restaurants wins ₹7.87 cr tax appeal, liability wiped out
The tribunal quashed a service tax demand that was roughly a third of the company's latest annual net profit, eliminating a decade-old contingent liability.
Exchanges reject SAB Events' promoter reclassification; son's MD role cited
The BSE and NSE refused to move promoter Markand Adhikari to the public category because his son, Kailasnath Markand Adhikari, holds a board seat and KMP role under SEBI LODR rules. The nano-cap company is mid-insolvency.
SEBI bans Mauria Udyog, promoters for 5 yrs over share-price rigging
Regulator confirms price and volume manipulation; five-year restriction adjusted for time served under interim order issued June 2023. Company maintains no material impact.
Ceigall's VP (Strategy) resigns – routine exit
Akshay Jain leaves for personal reasons; non-C-suite departure unlikely to affect a mid-cap infra builder riding 37.1% revenue growth.
Sylph Industries' MD quits nine days after CFO and three directors resign
The top executive departs within days of the entire top finance and independent board layer resigning. A company with a market cap of just over ₹30 crore now faces a leadership vacuum.
Star Cement's bid to reclassify 29 promoters as public is rejected
Exchanges say individual request letters were missing; the company may refile. The move signals a potential intent to reduce promoter stake over time.
NCLAT dismisses insolvency appeal, Ganesh Benzoplast wins legal fight
The appellate tribunal closed a case that sought to drag the chemical firm into insolvency over a subsidiary's guarantee. The dispute is over with no penalty.
Mahan Industries raises ₹29.83 cr, nearly 6x its market cap, in control-changing deal
The nano-cap NBFC's board approved preferential allotment of equity and warrants to incoming promoters, triggering an open offer that will shift control.
Sky Gold's ₹10.70 cr deepfake loss is a fraction of revenue
A subsidiary lost funds to a deepfake impersonation, but the hit is less than 0.15% of projected FY27 revenue. Core systems and customer data are safe.
Panacea Biotec gets HC stay on labour award recoveries
The company has now appealed all 4 tribunal awards. The High Court's interim order prevents coercive action on the first 3, reducing immediate enforcement risk.
Elgi's US unit pockets US$ 2.68M tariff refund after Supreme Court ruling
The refund, equal to ~20% of FY26 net profit, will boost consolidated earnings in the current quarter. It stems from a US Supreme Court order to repay excess tariffs.
Leading Leasing pulls ₹45 cr share issue, offers no explanation
The board withdrew applications for 40 crore shares to non-promoters and 5 crore shares to promoters. The move reverses a planned debt restructuring and leaves the company's capital plan in limbo.
AstraZeneca India gets CDSCO nod for Fasenra in rare hypereosinophilic syndrome
The approval expands the drug's use beyond severe asthma, but the patient pool for this rare disease is small. Financial impact is likely modest relative to recent oncology wins.
Jindal Photo delisting price set at ₹1,120 per share
Floor price of ₹1,119.50 determined by valuer; final price via reverse book-building. Public shareholding of 25.80% valued at ~₹296 cr at indicative price.
Kobo Biotech's resolution plan misses 10 July deadline, no funds yet
NCLT-approved ₹70.11 crore plan from Beaufond Industries was due within 60 days. As of 14 July, terms remain unfulfilled. Monitoring committee to decide next steps.
Anand Rathi's IFSC arm gets in-principle nod for GIFT City fund management
The subsidiary can now work towards final registration. The move is a logical extension of its mutual fund foray and incremental for a ₹32,087 cr wealth manager.
Advik Capital promoter arrested by ED
Vikas Garg taken into custody under PMLA on July 14. Prior asset attachment escalated to custodial detention for the ₹76-cr nano-cap NBFC.